OFFIPHARMA
Board
1 director, last change in 2021Director (not named in the articles)
since 13-04-2021
term without a fixed end
earlier manager, until 15-04-2021
listed in the 2025 annual accounts, filed on 31-08-2026
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Director (not named in the articles), from 13-04-2021 to date
- Manager, until 15-04-2021
Control
Capital
- Contribution
- €18,600
- Source
- 2025 annual accounts
Articles of association
deed of 15-04-2021 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié acquéreurs proportionnellement si plusieurs, nullité”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Saturday of May at 20:00
Capital transactions
Capital over time
- 15-04-2021 Converted to unavailable equity · €92,460
- 15-04-2021 Capital reduction of €72,000 · to €20,460 · repaid to the shareholders